Medical Research News

RSS

Key to controlling COVID-19 is early intervention

A study published in the journal Royal Society Open Science demonstrates the critical role of timely intervention in New Zealand's success story. The researchers used a stochastic branching process model to simulate the trajectory of COVID-19 transmission and control during New Zealand's 2020 outbreak. They calculated the number of reported cases and deaths and the probability of elimination within a defined time frame.

25 Nov 2021

Days of extreme heat associated with increased risk of emergency department visits

Extremely hot days with an average temperature of 34.4°C (93.9°F) are associated with a higher risk of emergency department visits among adults of all ages, finds a large study from the United States published by The BMJ today.

25 Nov 2021

Study analyzes factors that contribute to employee stress in the critical care environment

Hospital can be very challenging and stressful places in which to work. They are equipped to treat seriously ill patients who need constant monitoring, such as patients with severe COVID-19,those who require organ support or who are recovering from a major operation.

25 Nov 2021

Physical activity may prevent accumulation of metabolic risk factors in menopausal women

A study conducted at the University of Jyväskylä in the Faculty of Sport and Health Sciences shows that menopausal transition is associated with unfavourable changes in metabolic health that may be mitigated with a physically active lifestyle. Especially, physical activity alleviated the increase in systolic blood pressure.

25 Nov 2021

Using metal nanoparticles to fight SARS-CoV-2

A recent review article looks at the potential of nanotechnology in fighting severe acute respiratory syndrome 2 (SARS-CoV-2), with several possibilities of strategies in therapeutics, vaccines, and prevention.

25 Nov 2021

International collaboration secures €1M grant to investigate new treatment target for lymphoma

An international collaboration involving researchers from Queen Mary University of London, Memorial Sloan Kettering Cancer Center, New York and Dana-Farber Cancer Institute, Boston has secured a €1M research grant from Dutch blood cancer charity, Lymph&Co, to investigate a new treatment target for lymphoma.

25 Nov 2021

What may the future hold in terms of SARS-CoV-2 variants?

Researchers fit data on SARS-CoV-2 variants by exploiting a function that depends on the global number of infected cases since the start of the pandemic.

25 Nov 2021

COVID-19 vaccine boosters to prevent breakthrough SARS-CoV-2 infections in healthy adults

Researchers measured anti-RBD IgG and virus neutralization before and after vaccination with boosters.

25 Nov 2021

COVID-19 became more lethal in the U.K. in late 2020, statistical analysis suggests

A new statistical analysis supports beliefs that COVID-19 became more lethal in the U.K. in late 2020, while also suggesting that multiple factors - not just the alpha variant of the virus that causes COVID-19 - were to blame.

25 Nov 2021

Researchers map how far HIV patients live from access to care

In sub-Saharan Africa, 7 million people with HIV live more than 10 minutes from health care services and 1.5 million people with HIV live more than 60 minutes from a healthcare facility, according to a new study published this week in the open-access journal PLOS Global Public Health by Diego Cuadros of the University of Cincinnati, and colleagues.

25 Nov 2021

Direct-acting antivirals for HCV-related hepatocellular carcinoma reduces the risk of tumor progression

In a new cohort study of patients with hepatitis C virus (HCV)-related hepatocellular carcinoma (HCC), a disease with a high recurrence rate, researchers at the Osaka City University Graduate School of Medicine reported that after receiving cancer treatment, the oral administration of direct-acting antivirals (DAA) reduces the risk of tumor progression following recurrence of the liver disease.

25 Nov 2021

Scientists link increased air pollution to an uptick in cases of lung cancer

An international team of scientists, led by Nanyang Technological University, Singapore (NTU Singapore), has linked increased air pollution to an uptick in cases of lung adenocarcinoma (LADC) worldwide.

25 Nov 2021

Study demonstrates effectiveness of two doses of BBV152 vaccine against COVID-19

In a study published in The Lancet Infectious Diseases, researchers investigated the effectiveness of the BBV152 vaccine among employees of the All India Institute of Medical Sciences.

25 Nov 2021

Safety and immunogenicity of COVID-19 peptide vaccine

In a study published in Nature, researchers from University Hospital Tübingen have been investigating the results from a Phase I trial for a new vaccine against SARS-CoV-2 variants.

25 Nov 2021

Researchers investigate Moderna COVID-19 vaccine efficacy

Researchers have been investigating the vaccine efficacy of the mRNA-1273 vaccine.

25 Nov 2021

SARS-CoV-2 Delta variant mutation sites

A new review article dissected the sites of mutation in the RBD of the Delta variant and other variants of concern and variants of alert and interest.

25 Nov 2021

Study shows vaccinated multiple myeloma patients at greater risk of breakthrough SARS-CoV-2 infections

Researchers recently published a study assessing the risks of patients with MM to breakthrough infections after completing their vaccination schedule compared to those without any form of cancer.

25 Nov 2021

Cerba Research Expands U.S. Immuno-Oncology Center of Excellence to Strengthen Its Precision Medicine Offerings

Cerba Research recently expanded. Our U.S. Immuno-Oncology Center of Excellence allows us to provide even more comprehensive, integrated central lab services, specialty lab and biomarker solutions, and diagnostic services worldwide.

From Cerba Research 25 Nov 2021

Study finds under-representation of certain populations in cancer clinical trials

In a study examining disparities and trends in the inclusion of minorities, women, and older patients in cancer clinical trials, investigators found that certain populations remain under-represented.

25 Nov 2021

Breakthrough infections from SARS-CoV-2 Delta variant among vaccinated healthcare workers

A new study published on the medRxiv* preprint server employed in-silico techniques, combining genomic and epidemiological data, to determine possible Delta-variant transmission events between vaccinated healthcare workers (HCWs) in Indian hospitals.

25 Nov 2021

Medical Research News

Key to controlling COVID-19 is early intervention

Days of extreme heat associated with increased risk of emergency department visits

Study analyzes factors that contribute to employee stress in the critical care environment

Physical activity may prevent accumulation of metabolic risk factors in menopausal women

Using metal nanoparticles to fight SARS-CoV-2

International collaboration secures €1M grant to investigate new treatment target for lymphoma

What may the future hold in terms of SARS-CoV-2 variants?

COVID-19 vaccine boosters to prevent breakthrough SARS-CoV-2 infections in healthy adults

COVID-19 became more lethal in the U.K. in late 2020, statistical analysis suggests

Researchers map how far HIV patients live from access to care

Direct-acting antivirals for HCV-related hepatocellular carcinoma reduces the risk of tumor progression

Scientists link increased air pollution to an uptick in cases of lung cancer

Study demonstrates effectiveness of two doses of BBV152 vaccine against COVID-19

Safety and immunogenicity of COVID-19 peptide vaccine

Researchers investigate Moderna COVID-19 vaccine efficacy

SARS-CoV-2 Delta variant mutation sites

Study shows vaccinated multiple myeloma patients at greater risk of breakthrough SARS-CoV-2 infections

Cerba Research Expands U.S. Immuno-Oncology Center of Excellence to Strengthen Its Precision Medicine Offerings

Study finds under-representation of certain populations in cancer clinical trials

Breakthrough infections from SARS-CoV-2 Delta variant among vaccinated healthcare workers

Advancing Drug Safety Assessment With AI, Predictive Modeling, and Human-Relevant Data

AI-powered analytics and experimental validation

Membrane proteins in focus: Turning high-risk targets into routine workflows

Latest News